Back to BlackRock Finance, Inc. BlackRock Finance, Inc.

AGRX

2 quarters

Position history for BlackRock Finance, Inc.BlackRock Finance, Inc.'s holdings in AGILE THERAPEUTICS INC

No. BlackRock Finance exited its AGRX (Agile Therapeutics) position in Q1 2024. Its Q4 2023 13F listed 5,745 shares worth $11,203. BlackRock Finance held AGRX in 1 quarterly 13F filing before exiting.

Final Value

$0

Final Shares

0

Total Value Change

-$11,203

Total Shares Change

-5,745

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q1
Latest
Exited
0
-100.0%
$00.0%—
0
2023-Q4
First report
5,745
-
$11,2030.0%—
0

Other major holders of AGRX: Renaissance Technologies LLC, Citadel Advisors LLC, Geode Capital Management, LLC, State Street Corp.

Optional analytics helps us improve. How it’s used